REQUEST A DEMO
Total
USD $0.00
Search more companies

Locus Cell Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Locus Cell Co., Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Locus Cell Co., Ltd. is mainly engaged in the contract development and manufacturing organization(cdmo) serviceof cell therapy. The main products of company include CDMO services for cellular products. The company was established in 2020 and is headquartered in New Taipei City, Taiwan.

Headquarters
19F. -12, No. 97, Sec. 1, Xintai 5Th Rd, Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Locus Cell Co., Ltd. report to view the information.

Website: http://www.locus-cell.com

Basic Information
Total Employees:
Purchase the Locus Cell Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Locus Cell Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Locus Cell Co., Ltd. report to view the information.
Incorporation Date:
October 15, 2020
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
15%
Purchase this report to view the information.
13.96%
Purchase this report to view the information.
12.46%
Purchase this report to view the information.
5%
Purchase this report to view the information.
2.5%
Company Performance
Financial values in the chart are available after Locus Cell Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-6.88%
EBITDA
-108.64%
Net Profit (Loss) for the Period
-31.37%
Total assets
-1.98%
Total equity
-5.29%
Return on Equity (ROE)
-0.82%
Quick Ratio
-72.73%
Cash Ratio
-74.91%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?